89bio
ETNB
ETNB
160 hedge funds and large institutions have $1.11B invested in 89bio in 2023 Q3 according to their latest regulatory filings, with 28 funds opening new positions, 62 increasing their positions, 55 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
2% more funds holding
Funds holding: 157 → 160 (+3)
10.67% less ownership
Funds ownership: 106.01% → 95.34% (-11%)
24% less capital invested
Capital invested by funds: $1.46B → $1.11B (-$353M)
Holders
160
Holding in Top 10
4
Calls
$40.3M
Puts
$12.8M
Top Buyers
| 1 | +$24.6M | |
| 2 | +$7.39M | |
| 3 | +$7.36M | |
| 4 |
Barclays
London,
United Kingdom
|
+$6.61M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$6.48M |
Top Sellers
| 1 | -$39.8M | |
| 2 | -$25.6M | |
| 3 | -$16.2M | |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$14.1M |
| 5 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
-$12.2M |